Skip to main content

Table 5 Parasite prevalence and access to anti-malaria treatment

From: Gains attained in malaria control coverage within settings earmarked for pre-elimination: malaria indicator and prevalence surveys 2012, Eritrea

  Malaria parasite prevalence Access to anti-malaria treatment Children under 5 years
General population
% (95 % CI)
Children under 5 years
% (95 % CI)
Women aged 15–49 years
 % (95 % CI)
Had fever last 2 weeks
% (95 % CI)
Sought treatment/advice
% (95 % CI)
AS-AQ same day/next day
% (95 % CI)
Residency       
 Rural 1.3 % (1.0–1.6) 1.5 % (1.0–2.2) 1.9 % (1.4–2.5) 20 % (14–26) 56 % (52–67) 2.6 % (1.1–6.4)
 Urban 0.5 % (0.3–0.8) 0.9 % (0.4–2.3) 0.1 % (0.02–0.64) 19 % (10–31) 65 % (52–77) 0
Zoba       
 Anseba 0 0 0.2 % (0.1–0.8) 11 % (4–24) 60 % (46–75) 0
 Debub 0.8 % (0.5–1.2) 1.5 % (0.8–3.0) 2.1 % (1.3–3.3) 21 % (13–33) 58 % (46–70) 1.7 % (0.3–8.8)
 Gash Barka 2.6 % (2.1–3.2) 2.5 % (1.5–4.1) 1.9 % (1.5–3.8) 27 % (18–38) 63 % (52–73) 3.2 % (1.0–9.8)
 Semenawi Keih Bahri 0.1 % (0.02–0.31) 0.2 % (0.03–1.38) 0.1 % (0.01–0.72) 11 % (4–25) 64 % (46–77) 0
 Total 1.1 % (1.0–1.3) 1.4 % (1.0–2.0) 1.4 % (1.0–1.9) 19 % (15–26) 61 % (54–67) 2 % (0.8–4.9)
  1. N number, % frequency